Developer docs
API playgroundTry for free, no card

Search company profiles

QNTM Labs

Full company profile

uuid0008s3z

Namestring
QNTM Labs
Legal namestring
QNTM Labs
Websiteurl
qntmlabs.com
Company typeenum
Private
Founded yearint
2020
Descriptiontext

QNTM Labs is a GMP-certified contract service laboratory headquartered in Odense, Denmark, specializing in quality control activities for the pharmaceutical industry with strong expertise in small molecule drugs. The company operates from a state-of-the-art facility comprising approximately 1,000 square meters of laboratory space and 700 square meters of office space, equipped with advanced analytical instrumentation including HPLC, UPLC, GC, GC-MS, LC-MS, and ICP-MS, along with temperature- and humidity-controlled ICH-compliant stability chambers monitored 24/7. Service offerings span eight core GMP lines: Chemical Analysis, Microbiological Analysis, Method Development/Validation/Transfer, Stability & Photostability Studies, QC Release Analysis, Raw Materials & API Testing, Natural Product Testing (including Cannabis Flower monograph per Ph. Eur. and DAB), and Pesticide Residues Testing.

The company's commercial model is B2B contract laboratory services sold through direct engagement with pharmaceutical manufacturers, with quote-based pricing on project-based engagements ranging from single tests to integrated chemical and microbiological analysis packages. QNTM Labs addresses a clear customer pain point: pharma companies face rising QC demands and high fixed costs for in-house QC equipment and validation, and the company offers a flexible outsourcing alternative that lets clients reallocate internal resources to R&D or production while maintaining GMP compliance. The cannabis/herbal natural product line extends the addressable market beyond traditional small molecule pharma into a higher-growth adjacent segment.

QNTM Labs was founded in 2020 and obtained EU-GMP certification in late 2022, the same period in which it closed a Series A funding round led by Intrinsic Capital Partners. The company is privately held, headquartered at Unsbjergvej 4A, 5220 Odense SØ, Denmark, and operates with 11-50 employees. Founders Justin Ihnken (CEO) and Connor Jensen Murphy (COO) lead the company, which currently markets to a regional European pharmaceutical customer base.

Short descriptiontext

QNTM Labs is an EU-GMP-certified contract analytical laboratory in Odense, Denmark, providing pharmaceutical quality control services — chemical analysis, microbiological testing, method development/validation, stability studies, and release testing — to pharma manufacturers, with additional cannabis and herbal product testing capabilities.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersOdense, Denmark
HQ citystring
Odense
HQ countrystring
Denmark
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical contract testing, GMP laboratory services, analytical chemistry services, pharmaceutical quality control, microbiological testing services
Industry4 codes
PRIMARYHLAGADAC
Release Testing & Batch Certification (QC)
SECONDARYHLAGAKAD
Quality Management Systems (QMS) & GxP Documentation
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLAAAKAH
GMP Manufacturing Support Services (QA/QMS, validation, documentation)
SECONDARYHLAAAJAK
Quality Control (QC) Testing Technologies for Biomanufacturing (release/stability assays, rapid microbiology)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
NAICS code2 codes
  • Testing Laboratories and Services541380
  • Scientific Research and Development Services5417
SIC code2 codes
  • Services-Testing Laboratories8734
  • Services-Commercial Physical & Biological Research8731
Product category
Pharmaceutical Contract Testing Services
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Contract Laboratory Services
TypeProfessional Services
Description

QNTM Labs generates revenue through providing GMP-certified QC contract services to pharmaceutical companies. Services include chemical analysis, microbiological analysis, method development and validation, stability studies, and QC release testing. Revenue is generated through project-based engagements and service contracts with pharmaceutical clients requiring outsourced quality control activities.

qntmlabs.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

QNTM Labs is a GMP-certified contract service laboratory that performs pharmaceutical quality control testing on a fee-for-service basis. It delivers chemical analysis, microbiological analysis, method development and validation, ICH-compliant stability and photostability studies, QC release analysis, raw materials and API testing, natural product testing (including cannabis monograph analysis per Ph. Eur. and DAB), and pesticide residues testing for pharmaceutical companies seeking outsourced QC.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

QNTM Labs operates as a GMP-certified contract service laboratory offering an integrated portfolio of pharmaceutical quality control services. The core offering consists of eight specialized testing and analytical services: Chemical Analysis, Microbiological Analysis, Method Development Validation & Transfer, Stability & Photostability Studies (ICH), QC Release Analysis, Raw Materials & API Testing, Natural Product Testing, and Pesticide Residues Testing. These services work together as a unified quality control solution for pharmaceutical companies, providing comprehensive support from raw material testing through finished product release, with all analyses conducted according to ICH guidelines and international pharmacopeial standards.

Product and service1 record
1Chemical Analysis
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global leader in bioanalytical and pharmaceutical testing services with a dedicated pharma QC offering; competes head-to-head with QNTM Labs for European pharma QC contracts but operates at vastly greater scale across many verticals.

TypeBroad incumbent
Description

Swiss-based testing, inspection, and certification giant with a Life Sciences division offering pharmaceutical quality control and release testing; comparable end customers and service mix to QNTM Labs but at global incumbent scale.

TypeBroad incumbent
Description

Global TIC firm with a pharmaceutical services arm covering GMP testing, stability, and method validation; directly comparable service portfolio to QNTM Labs' QC release, stability, and chemical analysis offerings.

TypeBroad incumbent
Description

Major CRO/CDMO providing pharmaceutical quality control, release testing, and stability services to biopharma; overlaps with QNTM Labs' QC testing focus but serves a much larger customer base across multiple modalities.

TypeDirect peer
Description

UK/Northern Ireland-headquartered pharmaceutical services provider offering analytical services, method development/validation, stability testing, and QC release — a near mirror of QNTM Labs' service portfolio and customer base.

6Recipharm
TypeDirect peer
Description

European CDMO with integrated analytical and QC release testing services for small molecule drug substances and products; comparable in geography (Nordics/Europe), scale tier, and small-molecule focus to QNTM Labs.

TypeBroad incumbent
Description

Global CRO/CDMO providing laboratory testing and bioanalytical services to pharma; comparable QC testing capabilities but operates at much greater scale with a broader modality footprint.

TypeDirect peer
Description

Global CRO/CDMO with extensive analytical and pharmaceutical chemistry services including method development, validation, and QC testing; competes with QNTM Labs for European pharma QC outsourcing work.

TypeRegional player
Description

Danish contract research organization providing molecular biology, cell biology, and analytical services; comparable in geography and CRO business model though focused on biomedical rather than small-molecule QC.

TypeDirect peer
Description

Contract development and manufacturing organization offering analytical method development, validation, and quality control testing services for small molecule APIs and drug products — directly comparable service mix to QNTM Labs.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

QNTM Labs

Pharmaceutical Contract Testing Servicesqntmlabs.com

QNTM Labs is an EU-GMP-certified contract analytical laboratory in Odense, Denmark, providing pharmaceutical quality control services — chemical analysis, microbiological testing, method development/validation, stability studies, and release testing — to pharma manufacturers, with additional cannabis and herbal product testing capabilities.

What QNTM Labs does

QNTM Labs is a GMP-certified contract service laboratory headquartered in Odense, Denmark, specializing in quality control activities for the pharmaceutical industry with strong expertise in small molecule drugs. The company operates from a state-of-the-art facility comprising approximately 1,000 square meters of laboratory space and 700 square meters of office space, equipped with advanced analytical instrumentation including HPLC, UPLC, GC, GC-MS, LC-MS, and ICP-MS, along with temperature- and humidity-controlled ICH-compliant stability chambers monitored 24/7. Service offerings span eight core GMP lines: Chemical Analysis, Microbiological Analysis, Method Development/Validation/Transfer, Stability & Photostability Studies, QC Release Analysis, Raw Materials & API Testing, Natural Product Testing (including Cannabis Flower monograph per Ph. Eur. and DAB), and Pesticide Residues Testing.

The company's commercial model is B2B contract laboratory services sold through direct engagement with pharmaceutical manufacturers, with quote-based pricing on project-based engagements ranging from single tests to integrated chemical and microbiological analysis packages. QNTM Labs addresses a clear customer pain point: pharma companies face rising QC demands and high fixed costs for in-house QC equipment and validation, and the company offers a flexible outsourcing alternative that lets clients reallocate internal resources to R&D or production while maintaining GMP compliance. The cannabis/herbal natural product line extends the addressable market beyond traditional small molecule pharma into a higher-growth adjacent segment.

QNTM Labs was founded in 2020 and obtained EU-GMP certification in late 2022, the same period in which it closed a Series A funding round led by Intrinsic Capital Partners. The company is privately held, headquartered at Unsbjergvej 4A, 5220 Odense SØ, Denmark, and operates with 11-50 employees. Founders Justin Ihnken (CEO) and Connor Jensen Murphy (COO) lead the company, which currently markets to a regional European pharmaceutical customer base.

QNTM Labs firmographics

Firmographics
Name
QNTM Labs
Legal name
QNTM Labs
Website
https://qntmlabs.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
11–50 employees
Short description
QNTM Labs is an EU-GMP-certified contract analytical laboratory in Odense, Denmark, providing pharmaceutical quality control services — chemical analysis, microbiological testing, method development/validation, stability studies, and release testing — to pharma manufacturers, with additional cannabis and herbal product testing capabilities.
Ownership category
akta.pro rank

QNTM Labs industry classification

Industry
Product category
Pharmaceutical Contract Testing Services
NAICS
Testing Laboratories and Services (541380), Scientific Research and Development Services (5417)
SIC
Services-Testing Laboratories (8734), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGADAC
Release Testing & Batch Certification (QC)
SECONDARYHLAGAKAD
Quality Management Systems (QMS) & GxP Documentation
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLAAAKAH
GMP Manufacturing Support Services (QA/QMS, validation, documentation)
SECONDARYHLAAAJAK
Quality Control (QC) Testing Technologies for Biomanufacturing (release/stability assays, rapid microbiology)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)

Keywords

  • Pharmaceutical contract testing
  • GMP laboratory services
  • Analytical chemistry services
  • Pharmaceutical quality control
  • Microbiological testing services

Where QNTM Labs is headquartered

Location

Headquarters

HQ city
Odense
HQ country
Denmark
HQ region
Europe

Offices1 record

Markets served

QNTM Labs business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Contract Laboratory Services: QNTM Labs generates revenue through providing GMP-certified QC contract services to pharmaceutical companies. Services include chemical analysis, microbiological analysis, method development and validation, stability studies, and QC release testing. Revenue is generated through project-based engagements and service contracts with pharmaceutical clients requiring outsourced quality control activities.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

QNTM Labs product offering

Product offering

Core offering

QNTM Labs is a GMP-certified contract service laboratory that performs pharmaceutical quality control testing on a fee-for-service basis. It delivers chemical analysis, microbiological analysis, method development and validation, ICH-compliant stability and photostability studies, QC release analysis, raw materials and API testing, natural product testing (including cannabis monograph analysis per Ph. Eur. and DAB), and pesticide residues testing for pharmaceutical companies seeking outsourced QC.

Product overview

QNTM Labs operates as a GMP-certified contract service laboratory offering an integrated portfolio of pharmaceutical quality control services. The core offering consists of eight specialized testing and analytical services: Chemical Analysis, Microbiological Analysis, Method Development Validation & Transfer, Stability & Photostability Studies (ICH), QC Release Analysis, Raw Materials & API Testing, Natural Product Testing, and Pesticide Residues Testing. These services work together as a unified quality control solution for pharmaceutical companies, providing comprehensive support from raw material testing through finished product release, with all analyses conducted according to ICH guidelines and international pharmacopeial standards.

Differentiator

Problem solved

Functional benefit

Products and services

  • Chemical Analysis

Companies that use QNTM Labs

Customer profile

Segments2 records

Ideal customer profiles2 records

QNTM Labs technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

QNTM Labs partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves4 records

Expansion highlights5 records

QNTM Labs competitors and assessment

Company assessment

Broad incumbents

  • Eurofins Scientific: Global leader in bioanalytical and pharmaceutical testing services with a dedicated pharma QC offering; competes head-to-head with QNTM Labs for European pharma QC contracts but operates at vastly greater scale across many verticals.
  • SGS Société Générale de Surveillance: Swiss-based testing, inspection, and certification giant with a Life Sciences division offering pharmaceutical quality control and release testing; comparable end customers and service mix to QNTM Labs but at global incumbent scale.
  • Intertek Group: Global TIC firm with a pharmaceutical services arm covering GMP testing, stability, and method validation; directly comparable service portfolio to QNTM Labs' QC release, stability, and chemical analysis offerings.
  • Charles River Laboratories: Major CRO/CDMO providing pharmaceutical quality control, release testing, and stability services to biopharma; overlaps with QNTM Labs' QC testing focus but serves a much larger customer base across multiple modalities.
  • WuXi AppTec: Global CRO/CDMO providing laboratory testing and bioanalytical services to pharma; comparable QC testing capabilities but operates at much greater scale with a broader modality footprint.

Direct peers

  • Almac Group: UK/Northern Ireland-headquartered pharmaceutical services provider offering analytical services, method development/validation, stability testing, and QC release — a near mirror of QNTM Labs' service portfolio and customer base.
  • Recipharm: European CDMO with integrated analytical and QC release testing services for small molecule drug substances and products; comparable in geography (Nordics/Europe), scale tier, and small-molecule focus to QNTM Labs.
  • Pharmaron: Global CRO/CDMO with extensive analytical and pharmaceutical chemistry services including method development, validation, and QC testing; competes with QNTM Labs for European pharma QC outsourcing work.
  • Cambrex Corporation: Contract development and manufacturing organization offering analytical method development, validation, and quality control testing services for small molecule APIs and drug products — directly comparable service mix to QNTM Labs.

Regional players

  • Bioneer A/S: Danish contract research organization providing molecular biology, cell biology, and analytical services; comparable in geography and CRO business model though focused on biomedical rather than small-molecule QC.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

QNTM Labs compliance and trust

Trust signal

Compliance1 record

QNTM Labs financial estimates

Financial estimate

Revenue estimate

Valuation estimate

QNTM Labs leadership team

Management profile

Number of profiles

Profiles2 records

QNTM Labs funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

QNTM Labs M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about QNTM Labs

What does QNTM Labs do?

QNTM Labs is a GMP-certified contract service laboratory that performs pharmaceutical quality control testing on a fee-for-service basis. It delivers chemical analysis, microbiological analysis, method development and validation, ICH-compliant stability and photostability studies, QC release analysis, raw materials and API testing, natural product testing (including cannabis monograph analysis per Ph. Eur. and DAB), and pesticide residues testing for pharmaceutical companies seeking outsourced QC.

Is QNTM Labs a public or private company?

QNTM Labs is a private company. It is classified as venture growth investor backed and is currently operating.

When was QNTM Labs founded?

QNTM Labs was founded in 2020. It employs 11 to 50 people.

Where is QNTM Labs based?

QNTM Labs is headquartered in Odense, Denmark, in the Europe region.

How does QNTM Labs make money?

One revenue line is on record: contract Laboratory Services.

Who are QNTM Labs's main competitors?

Broad incumbents on record are Eurofins Scientific, SGS Société Générale de Surveillance, Intertek Group, Charles River Laboratories and WuXi AppTec. Direct peers are Almac Group, Recipharm, Pharmaron and Cambrex Corporation. Bioneer A/S is listed as a regional player.

Does QNTM Labs have an API?

No public API is recorded for QNTM Labs.

What industry is QNTM Labs in?

QNTM Labs's product category is Pharmaceutical Contract Testing Services. Its primary akta.pro industry code is HLAGADAC, Release Testing & Batch Certification (QC), with a secondary code of HLAGAKAD, Quality Management Systems (QMS) & GxP Documentation. Its NAICS code is 541380 and its SIC code is 8734.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireQNTM Labs Closes Series A Led by Intrinsic Capital Partners to Reinvent Pharmaceutical Lab Testing on a Global ScaleQNTM Labs, a Danish pharmaceutical lab, closed a Series A led by Intrinsic Capital Partners and received EU-GMP certification. The funding will help scale its analytical capabilities and address bottlenecks in pharmaceutical lab testing. The company aims to become a global leader in lab testing.GlobeNewswireQNTM Labs Closes Series A Led by Intrinsic Capital Partners to Reinvent Pharmaceutical Lab Testing on a Global ScaleQNTM Labs, a Danish pharmaceutical lab, closed a Series A led by Intrinsic Capital Partners and received EU-GMP certification. The funding will help scale its analytical capabilities and address bottlenecks in pharmaceutical lab testing. The company aims to become a leader in lab testing for plant-based pharmaceuticals.BioSpaceQNTM Labs Closes Series A Led by Intrinsic Capital Partners to Reinvent Pharmaceutical Lab Testing on a Global ScaleQNTM Labs, a pharmaceutical laboratory based in Denmark, has closed a Series A funding round led by Intrinsic Capital Partners to scale its analytical testing capabilities. The company also recently obtained an EU-GMP license, which supports its mission to improve transparency and access to high-quality analysis in the pharmaceutical value chain.PR NewswireKnowde Group Inc.™ launches in the UK with the addition of Chief Medical Officer, Project Lead, and announces strategic partnership with QNTM LabsKnowde Group Inc. incorporated in the UK and announced a strategic partnership with QNTM Labs in Denmark. The partnership aims to support GMP-level analysis and clinical trials for cannabinoid products. The company also appointed Chief Medical Officer Dr. Steve Hajioff and UK Project Manager Eleanor Owen-Jones.